OBJECTIVE:To perform a molecular characterization of the C1q, C2 and C4 genes in patients with juvenile systemic lupus erythematosus.METHODS:Patient 1 (P1) had undetectable C1q, patient 2 (P2) and patient 3 (P3) had decreased C2 and patient 4 (P4) had decreased C4 levels. All exons and non-coding regions of the C1q and C2 genes were sequenced. Mononuclear cells were cultured and stimulated with interferon gamma to evaluate C1q, C2 and C4 mRNA expression by quantitative real-time polymerase chain reaction.RESULTS:C1q sequencing revealed heterozygous silent mutations in the A (c.276 A>G Gly) and C (c.126 C>T Pro) chains, as well as a homozygous single-base change in the 3′ non-coding region of the B chain (c*78 A>G). C1qA mRNA expression without interferon was decreased compared with that of healthy controls (p<0.05) and was decreased after stimulation compared with that of non-treated cells. C1qB mRNA expression was decreased compared with that of controls and did not change with stimulation. C1qC mRNA expression was increased compared with that of controls and was even higher after stimulation. P2 and P3 had Type I C2 deficiency (heterozygous 28 bp deletion at exon 6). The C2 mRNA expression in P3 was 23 times lower compared with that of controls and did not change after stimulation. The C4B mRNA expression of P4 was decreased compared with that of controls and increased after stimulation.CONCLUSIONS:Silent mutations and single-base changes in the 3′ non-coding regions may modify mRNA transcription and C1q production. Type I C2 deficiency should be evaluated in JSLE patients with decreased C2 serum levels. Further studies are needed to clarify the role of decreased C4B mRNA expression in JSLE pathogenesis.
Background It was not already defined whether standard measures are sufficient to asses primary C1q, C2 and C4 deficiencies1-3. Objectives To perform C1q, C2 and C4 molecular characterization in Juvenile Systemic Lupus Erythematosus (JSLE) patients. Methods From JSLE cohort screened for complement deficiencies2 were selected P1 with undetectable C1q and normal C3 and C4; P2 with decreased C2 and C4; P3 with decreased C2, normal C3 and C4 and P4 with repeated decreased C4, normal C1q, C2 and C3. Primers were according to GenBank. Peripheral mononuclear cells from patients and 3 healthy controls were cultivated, stimulated with interferon gama, incubated for 36 h and quantitative RT-PCR verified gene mRNA expression. Results C1q characterization (P1) revealed heterozygous silent mutations in A chain (c.276 A>G Gly) and C chain (c.126 C>T Pro). Two homozygous single-base exchanges were found in 5´UTR (c. -159 T>G) and 3’UTR (c*78 A>G) in B chain. Patient’s healthy mother had the same homozygous silent mutation in A chain, heterozygous silent mutation in C chain and single-base exchanges in B chain. She also had missense mutation in A chain (c.295 A>C Ile>Leu). Quantitative RT-PCR showed that (P1) C1qA gene mRNA expression without stimulation was 1.3 times decreased and with interferon gama was 1.6 times more expressed compare with healthy samples. C1qB gene expression without stimulation was 2.2 times decreased and stimulated was 1.5 times increased. Controls did not expressed C1qC and patient had low expression without and with stimulation. P2 and P3 had heterozygous C2 deficiency type I (28 bp deletion) and P2 also had 2 copies of C4A and 1 of C4B. The sequencing showed that exons, splicing sites, 5’UTR and 3’UTR matched 100% with reference sequence, exception to 28bp deletion. Patients’ mRNA expressions without stimulation was 23 times decreased and with interferon was 1.5 times increased. P4 had 2 copies of C4A and 3 of C4B and RT-PCR showed that C4B expression without stimulation was 14 times decreased and with interferon was 1.1 times increased. The C4A gene expression was not performed. Conclusions We speculate whether single-base exchanges in 5’UTR in B chain, that correspond to promoter region, and in 3’UTR, that correspond to stabilization mRNA region, may have modified the transcription as it expression was decreased without stimulation. Further analyzes may relate C1q gene variations and undetectable C1q. In addition, heterozygous C2 deficiency type I leaded to reduced mRNA expression and may be present in JSLE patients with detectable C2 levels. Finally, C4B gene expression was decreased and shows that serum dosage and gene copy number may not be sufficient to asses C4 deficiency. References Carneiro-Sampaio M, et al. Understanding Systemic Lupus Erythematosus Physiopathology in the Light of Primary Immunodeficiencies. J Clin Immunol. 2008;28:S34-S41; Jesus AA, et al. Complement and antibody primary immunodeficiency in juvenile systemic lupus erythematosus patients. Lupus 2011;20:1275-84; B...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.